Enhanced drug metabolism in young children with cystic fibrosis. - Wikidata - wikimedia - TriplyDB

Enhanced drug metabolism in young children with cystic fibrosis.

Enhanced drug metabolism in young children with cystic fibrosis.

http://www.wikidata.org/entity/Q35256801

about

Drug trials in children: problems and the way forward [13C]aminopyrine and [13C]caffeine breath test: influence of gender, cigarette smoking and oral contraceptives intake.Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease Potential of anti-inflammatory treatment for cystic fibrosis lung disease.Effect of Casilan(®) on (13)C-caffeine metabolism in overnight-fasted healthy Nigerian children Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice Is there an advantage in normalising the results of the Helicobacter pylori [13C]urea breath test for CO2 production rate in children?Comparison of accuracy and precision of heart rate calibration methods to estimate total carbon dioxide production during 13C-breath tests.Oxidative stress and heart failure in altered thyroid States

P2860

Q33836061-AD0A9F6F-E939-4EC5-8B41-E1E6A882E03D Q33961262-D1A6A1BC-F6C2-4683-80AA-0C2F10411EE4 Q35164509-0258E9BB-7DBF-4F8A-AAC6-B0461747C3BA Q35557381-63290D21-D052-4904-9400-5DBFB8C3FD9C Q36813799-10B0115C-9F5E-4215-9579-6E76956C11F7 Q37162444-1395FFAB-598F-453B-A1F6-56D5ADAA0438 Q44845696-7B3D09CF-2223-402B-B220-F5BEF8635575 Q47731468-283A1D7E-F290-4B5A-88E3-71FAB356A332 Q58915024-C9ED02C9-2871-4892-9DAB-86EFCFD6E620

P2860

Enhanced drug metabolism in young children with cystic fibrosis.

http://www.wikidata.org/entity/Q35256801

description

1997 nî lūn-bûn

@nan

1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

name

Enhanced drug metabolism in young children with cystic fibrosis.

@ast

Enhanced drug metabolism in young children with cystic fibrosis.

@en

type

label

Enhanced drug metabolism in young children with cystic fibrosis.

@ast

Enhanced drug metabolism in young children with cystic fibrosis.

@en

prefLabel

Enhanced drug metabolism in young children with cystic fibrosis.

@ast

Enhanced drug metabolism in young children with cystic fibrosis.

@en

P1433

Q35256801-45E67747-BDB0-411B-83CC-E74B4CFC569D

P1476

Q35256801-C529A691-D042-4E7C-84BB-8A7C37303926

P2093

Q35256801-07DC54DE-924F-4E28-8144-527ACA34592E

Q35256801-3C7A231C-98BC-479D-8BAA-3C812165572F

Q35256801-90FAD827-5DFF-45CC-B9FD-29B4BCC82FB6

Q35256801-98C005E1-FF69-430D-9ECF-21129C408041

Q35256801-AA82EBD6-0543-4F4B-859C-55D8C4123899

P2860

Q35256801-3975CF54-A94A-4116-A224-57552C0B349F

Q35256801-43D5A4E8-0AB4-4A7F-A89A-47942143CD2C

Q35256801-43F128EA-56BA-46E6-B47B-54D5F3F5FB67

Q35256801-59DE8D47-66F9-47C2-A0F3-9C762DBC4AED

Q35256801-7A46281D-007C-40DC-B283-7EE5AEF5630F

Q35256801-840FE0EA-ED0A-4642-9D12-595A051620C3

Q35256801-B045D8C6-4747-4320-BE1B-ACD23A7768CB

Q35256801-D8F0A975-F401-4771-82AF-8D7CB88D454F

Q35256801-E8C72250-5F9A-496B-AF7E-A8047A47E6CC

Q35256801-F5E4961E-0DE6-4F38-9BFB-E8A91F4CB541

P304

Q35256801-392C1DE6-7780-42E7-B7E3-B1D39911B640

P31

Q35256801-8B4008D4-505D-40E5-8FD9-BB2F4E6D8E28

P356

Q35256801-209B122C-8455-45BF-9FD1-E4D7C01F211E

P407

Q35256801-1BD3C0FD-919A-417F-9423-AD147504D924

P433

Q35256801-632E8716-8C07-4CDE-955E-77A56CA660E7

P478

Q35256801-436A1C84-396A-43C8-829B-1560CD675B82

P577

Q35256801-82E36CFC-F07E-469B-A7FF-37DB13171DA5

P5875

Q35256801-C669E2B8-96EA-44A5-BE72-2FEB6F83843A

P698

Q35256801-B69E597C-B6EE-4758-B553-49A5A22CC788

P921

Q35256801-1BE9E4E8-C261-430E-910A-5935B00ED8B5

P932

Q35256801-AA00E254-2E6B-4660-8F56-D5C9BBC8CAA6

P356

P1433

Archives of Disease in Childhood

P1476

Enhanced drug metabolism in young children with cystic fibrosis.

@en

P2093

A C Parker

http://www.w3.org/2001/XMLSchema#string

I Choonara

http://www.w3.org/2001/XMLSchema#string

P Pritchard

http://www.w3.org/2001/XMLSchema#string

R L Smyth

http://www.w3.org/2001/XMLSchema#string

T Preston

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test

Theophylline disposition in cystic fibrosis.

Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.

Pulmonary disease and drug kinetics.

The CO2 breath tests as monitors of the cytochrome P450 dependent mixed function monooxygenase system.

The chest radiograph in cystic fibrosis: a new scoring system compared with the Chrispin-Norman and Brasfield scores.

Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease.

Enhanced hepatic drug clearance in patients with cystic fibrosis.

Pharmacokinetics of unchanged morphine in normal and cirrhotic subjects.

Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin.

P304

239-241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ADC.77.3.239

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P577

1997-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13858835

http://www.w3.org/2001/XMLSchema#string

P698

9370904

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

1717318

http://www.w3.org/2001/XMLSchema#string